UK-based pharmaceutical giant AstraZeneca said Tuesday it will release further data “within 48 hours” on US trials of its COVID-19 vaccine, after health officials raised concerns about the initial information disclosed. The company pushed back against a statement from the…
Read MoreKHN’s ‘What the Health?’: Vaccines Coming Soon but COVID Relief Bill Still Stalled
Can’t see the audio player? Click here to listen on SoundCloud. The first vaccine to protect against COVID-19 could be approved in the U.S. within days, but legislation to help fund its distribution remains mired in Congress. And President-elect Joe Biden…
Read MoreEven With ACA’s Fate in Flux, Open Enrollment Starts Soon. Here’s What’s New.
Facing a pandemic, record unemployment and unknown future costs for COVID-19 treatments, health insurers selling Affordable Care Act plans to individuals reacted by lowering rates in some areas and, overall, issuing only modest premium increases for 2021. “What’s been fascinating…
Read More